A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use

Insulin degludec/insulin aspart (IDegAsp; 70 % IDeg and 30 % IAsp) is a soluble combination of two individual insulin analogues in one product, designed to provide mealtime glycaemic control due to the IAsp component and basal glucose-lowering effect from the IDeg component. The pharmacokinetic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Haahr, Hanne, Fita, Edmond G., Heise, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340839/
https://www.ncbi.nlm.nih.gov/pubmed/27696221
http://dx.doi.org/10.1007/s40262-016-0455-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340839/
https://www.ncbi.nlm.nih.gov/pubmed/27696221
http://dx.doi.org/10.1007/s40262-016-0455-7

Ejemplares similares